Current Issue

Sponsored
Keywords

Biodefense - Related Content

BioPerspectives: Government Panel Makes the Right Move on Avian Flu Research
Point of View: Do-It-Yourself Bioengineers Bedeviled by Society's Paranoia
Current Stance against Independent Biological Innovation Is Counterproductive
Feature Articles: New Capabilities Fortify Biodefense Tools
Rise in Funding for Rapid Diagnostics Has Resulted in Innovative Biodetection Systems
Corporate Profiles: PharmAthene Secures Biodefense Position
Company Stays Solely Focused on Developing Bioterrorism Countermeasure Products
Feature Articles: Identifying Biochemical Threats Earlier
Companies Scramble to Devise More Rapid Methods of Biological and Chemical Detection

Challenge: Surface Sampler
May 3, 2013
This is a device originally devised to protect soldiers from biological and chemical warfare. Can you think of a novel way to use this technology? Enter for a shot at prizes!
Defense Authorization Measure Yields Less for Chem-Bio Defense, More for Cooperative Biodefense Engagement
January 26, 2012
CBEP is trying to expand its centers of excellence beyond the former Soviet Union nations.
House, Senate Look to PAHPA Reauthorization to Stoke Biodefense Initiave
December 22, 2011
Bill has passed the House and was the subject of a closed-door executive session in the Senate on December 14.
A Decade after 9/11, Spending Cuts Challenge Biodefense Effort Spawned by Attacks
September 11, 2011
The House approved a budget for Homeland Security that is $1.1 billion below FY ’11 spending.
Japan Disaster Renews Interest in Antiradiation Drug Development
April 25, 2011
BARDA's flexibility in dealing with industry is improving investor's confidence in biodefense.

Presidential Commission’s Report on Synthetic Biology
Drew Endy is an assistant professor of bioengineering at Stanford University. He earned a BS and MS in civil and environmental engineering, respectively, from Lehigh University and a Ph.D. in biochemical engineering from Dartmouth College.